|
Market Closed -
London S.E.
11:20:00 2026-10-02 am EDT
|
5-day change | 1st Jan Change | ||
| 323.90 CHF | 0.00% |
|
0.00% | -1.29% |
| Sep. 13 | Roche Outlines Positive Phase 3 Trial Data for Small-cell Lung Cancer Treatment in China | MT |
| Sep. 11 | Scholar Rock gets first FDA nod for rare muscle-wasting disease (September 11) | RE |
| Market Cap | 277B 334B 297B 252B 476B 32,157B 480B 3,344B 1,300B 16,397B 1,254B 1,226B 52,638B | P/E 2026 * |
18.8x | P/E 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise Value | 287B 347B 308B 262B 494B 33,422B 499B 3,475B 1,351B 17,042B 1,303B 1,275B 54,709B | EV / Sales 2026 * |
4.58x | EV / Sales 2027 * | 4.28x |
| Free-Float |
88.78% | Yield 2026 * |
2.9% | Yield 2027 * | 2.97% |
Last Transcript: Roche Holding AG
| Current month | +0.48% | ||
| Current year | -1.29% |
| Current year | 311.6 |  | 377 |
| 1 year | 258.4 | | 377 |
| 3 years | 212.3 | | 377 |
| 5 years | 212.3 | | 404.1 |
| 10 years | 202.23 | | 404.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2023-03-14 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 2011-06-05 |
| Chief Operating Officer | - | 2025-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 1995-12-31 |
Severin Schwan
CHM | Chairman | 59 | 2023-03-14 |
| Director/Board Member | 73 | 2015-03-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 333B | |
| -0.61% | -3.43% | +36.07% | +115.04% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.63% | 617B | |
| +1.11% | -0.58% | +12.36% | +77.95% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.24% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +51.84% | 218B | |
| -1.87% | -4.10% | +28.44% | +93.66% | 179B | |
| Average | -0.68% | -3.39% | +26.07% | +57.78% | 410.8B | |
| Weighted average by Cap. | -0.55% | -3.33% | +29.07% | +69.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.69B 75.67B 67.23B 57.13B 108B 7,290B 109B 758B 295B 3,717B 284B 278B 11,934B | 65.54B 79.11B 70.29B 59.73B 113B 7,622B 114B 793B 308B 3,886B 297B 291B 12,477B |
| Net income | 14.49B 17.49B 15.54B 13.21B 24.93B 1,685B 25.16B 175B 68.14B 859B 65.7B 64.28B 2,759B | 16.32B 19.7B 17.51B 14.88B 28.08B 1,898B 28.34B 197B 76.75B 968B 74B 72.4B 3,107B |
| Net Debt | 10.88B 13.13B 11.66B 9.91B 18.71B 1,265B 18.89B 132B 51.14B 645B 49.31B 48.24B 2,071B | 4.03B 4.87B 4.33B 3.68B 6.94B 469B 7B 48.78B 18.97B 239B 18.29B 17.89B 768B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | CHF 323.90 | 0.00% | 3,929 |
| 26-10-01 | CHF 323.90 | 0.00% | 52,729 |
| 26-09-30 | CHF 323.90 | 0.00% | 37,738 |
| 26-09-29 | CHF 323.90 | 0.00% | 7,696 |
| 26-09-28 | CHF 323.90 | 0.00% | 9,693 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROP Stock
- 0QOK Stock
Select your edition
All financial news and data tailored to specific country editions
